Clinical Performance Measures for Emergency Department Care for Adults With Intracranial Hemorrhage.
暂无分享,去创建一个
J. Goldstein | O. Adeoye | A. Venkatesh | K. Zachrison | R. Radecki | L. Ganti | J. Oostema | Tracy E. Madsen | B. Lo | Pawan Goyal | W. Meurer | V. Feeser | C. Rothenberg | E. Jauch | Mitra Corral | Anshita Chaturvedi
[1] J. Mocco,et al. 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association. , 2022, Stroke.
[2] A. Janke,et al. National trends in emergency department closures, mergers, and utilization, 2005-2015 , 2021, PloS one.
[3] A. Demchuk,et al. Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage , 2021, Stroke.
[4] O. Sadan,et al. Aneurysmal Subarachnoid Hemorrhage: Trends, Outcomes, and Predictions From a 15-Year Perspective of a Single Neurocritical Care Unit , 2020, Neurosurgery.
[5] E. Finn,et al. A Multimodal Intervention to Improve the Quality and Safety of Interhospital Care Transitions for Nontraumatic Intracerebral and Subarachnoid Hemorrhage. , 2020, Joint Commission journal on quality and patient safety.
[6] A. Charidimou,et al. Noncontrast CT markers of intracerebral hemorrhage expansion and poor outcome , 2020, Neurology.
[7] K. Derry,et al. Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products , 2020, Journal of Thrombosis and Thrombolysis.
[8] J. Goldstein,et al. Ultra‐Early Blood Pressure Reduction Attenuates Hematoma Growth and Improves Outcome in Intracerebral Hemorrhage , 2020, Annals of neurology.
[9] G. Brophy,et al. Factor Xa Inhibitor-Related Intracranial Hemorrhage , 2020, Circulation.
[10] K. Colton,et al. Early Stroke Recognition and Time-based Emergency Care Performance Metrics for Intracerebral Hemorrhage. , 2019, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[11] L. Schwamm,et al. Resource utilisation among patients transferred for intracerebral haemorrhage , 2019, Stroke & Vascular Neurology.
[12] W. Wright,et al. Clinical Performance Measures for Neurocritical Care: A Statement for Healthcare Professionals from the Neurocritical Care Society , 2019, Neurocritical care.
[13] C. Anderson,et al. Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a preplanned pooled analysis of individual participant data , 2019, The Lancet Neurology.
[14] Lai,et al. Meta-Analysis of Accuracy of the Spot Sign for Predicting Hematoma Growth and Clinical Outcomes. , 2019, Stroke.
[15] C. Matouk,et al. A Qualitative Study of Risks Related to Interhospital Transfer of Patients with Nontraumatic Intracranial Hemorrhage. , 2019, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[16] A. Demchuk,et al. Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors , 2019, The New England journal of medicine.
[17] A. Sweidan,et al. Contemporary Reversal of Oral Anticoagulation in Intracerebral Hemorrhage , 2019, Stroke.
[18] H. Schünemann,et al. Management of direct factor Xa inhibitor-related major bleeding with prothrombin complex concentrate: a meta-analysis. , 2019, Blood advances.
[19] A. J. Roberts,et al. Effect of low and moderate dose FEIBA to reverse major bleeding in patients on direct oral anticoagulants. , 2019, Thrombosis research.
[20] Y. Fujii,et al. Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data , 2018 .
[21] Bainan Xu,et al. Accuracy of spot sign in predicting hematoma expansion and clinical outcome , 2018, Medicine.
[22] D. Heyland,et al. Outcomes and Costs of Patients Admitted to the ICU Due to Spontaneous Intracranial Hemorrhage , 2018, Critical care medicine.
[23] Mary G. George,et al. Clinical Performance Measures for Adults Hospitalized With Intracerebral Hemorrhage: Performance Measures for Healthcare Professionals From the American Heart Association/American Stroke Association , 2014, Stroke.
[24] Zhenxing Li,et al. Effects of Intensive Blood Pressure Reduction on Acute Intracerebral Hemorrhage: A Systematic Review and Meta-analysis , 2017, Scientific Reports.
[25] T. Steiner,et al. Idarucizumab for Dabigatran Reversal — Full Cohort Analysis , 2017, The New England journal of medicine.
[26] L. Schwamm,et al. The American Heart Association’s Get With the Guidelines (GWTG)-Stroke development and impact on stroke care , 2017, Stroke and Vascular Neurology.
[27] B. Ritchie,et al. Reversal of dabigatran-associated major bleeding with activated prothrombin concentrate: A prospective cohort study. , 2017, Thrombosis research.
[28] M. Silvestrini,et al. How Should We Lower Blood Pressure after Cerebral Hemorrhage? A Systematic Review and Meta-Analysis , 2017, Cerebrovascular Diseases.
[29] A. Charidimou,et al. Intensive blood pressure lowering in patients with acute intracerebral haemorrhage: clinical outcomes and haemorrhage expansion. Systematic review and meta-analysis of randomised trials , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.
[30] R. Bellomo,et al. Subarachnoid Hemorrhage Patients Admitted to Intensive Care in Australia and New Zealand: A Multicenter Cohort Analysis of In-Hospital Mortality Over 15 Years , 2017, Critical care medicine.
[31] Rustam Al-Shahi Salman,et al. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial , 2016, The Lancet.
[32] D. Hanley,et al. Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage. , 2016, The New England journal of medicine.
[33] P. Bath,et al. Blood pressure management in acute stroke , 2016, Stroke and Vascular Neurology.
[34] W. Hacke,et al. Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial , 2016, The Lancet Neurology.
[35] Na Li,et al. Predicting Intracerebral Hemorrhage Growth With the Spot Sign: The Effect of Onset-to-Scan Time , 2016, Stroke.
[36] C. Anderson,et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2015, Stroke.
[37] M. Woodward,et al. Magnitude of blood pressure reduction and clinical outcomes in acute intracerebral hemorrhage: intensive blood pressure reduction in acute cerebral hemorrhage trial study. , 2015, Hypertension.
[38] M. Woodward,et al. Rapid Blood Pressure Lowering According to Recovery at Different Time Intervals after Acute Intracerebral Hemorrhage: Pooled Analysis of the INTERACT Studies , 2015, Cerebrovascular Diseases.
[39] T. Beasley,et al. Prolonged Emergency Department Length of Stay as a Predictor of Adverse Outcomes in Patients with Intracranial Hemorrhage , 2015, Journal of critical care medicine.
[40] Eric E. Smith,et al. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative. , 2014, JAMA.
[41] M. Woodward,et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. , 2013, The New England journal of medicine.
[42] B. Norrving,et al. Long term (13 years) prognosis after primary intracerebral haemorrhage: a prospective population based study of long term mortality, prognostic factors and causes of death , 2013, Journal of Neurology, Neurosurgery & Psychiatry.
[43] A. Demchuk,et al. The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial , 2013, Stroke.
[44] R. Tamargo,et al. Impact of pattern of admission on outcomes after aneurysmal subarachnoid hemorrhage. , 2012, Journal of critical care.
[45] D. Drazin,et al. The Effect of Transfer and Hospital Volume in Subarachnoid Hemorrhage Patients , 2012, Neurocritical Care.
[46] Adrian F Hernandez,et al. Comparison of 30-day mortality models for profiling hospital performance in acute ischemic stroke with vs without adjustment for stroke severity. , 2012, JAMA.
[47] Paul Vespa,et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2012, Stroke.
[48] A. Demchuk,et al. Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study , 2012, The Lancet Neurology.
[49] Derek C Angus,et al. Reorganizing adult critical care delivery: the role of regionalization, telemedicine, and community outreach. , 2010, American journal of respiratory and critical care medicine.
[50] Mitchell S. V. Elkind,et al. Impact of Delayed Transfer of Critically Ill Stroke Patients from the Emergency Department to the Neuro-ICU , 2010, Neurocritical care.
[51] M. Hartmann,et al. Hematoma Growth and Outcome in Treated Neurocritical Care Patients With Intracerebral Hemorrhage Related to Oral Anticoagulant Therapy: Comparison of Acute Treatment Strategies Using Vitamin K, Fresh Frozen Plasma, and Prothrombin Complex Concentrates , 2006, Stroke.
[52] S M Davis,et al. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage , 2006, Neurology.
[53] W. Ageno,et al. Management of coumarin-associated coagulopathy in the non-bleeding patient: a systematic review. , 2004, Haematologica.
[54] H. Naritomi,et al. Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication. , 2002, Thrombosis research.
[55] W R Clarke,et al. Baseline NIH Stroke Scale score strongly predicts outcome after stroke , 1999, Neurology.